JAK inhibitors and the risk of cardiovascular and venous thromboembolism events among patients with rheumatoid arthritis: A network meta-analysis of clinical trials

被引：0
|
作者：
Alves, Carlos [1 ]
Penedones, Ana [2 ]
Mendes, Diogo [2 ]
Marques, Francisco Batel [1 ]
机构：
[1] Univ Coimbra, Fac Pharm, Coimbra, Portugal
[2] AIBILI, UFC Coimbra Reg Pharmacovigilance Unit, CHAD Ctr Hlth Technol Assessment & Drug Res, Coimbra, Portugal
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [1] RISK OF CARDIOVASCULAR AND VENOUS THROMBOEMBOLISM EVENTS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS
    Penedones, Ana
    Alves, Carlos
    Mendes, Diogo
    Batel-Marques, Francisco
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 25 - 25
  • [2] RISK OF INFECTIONS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS
    Penedones, Ana
    Alves, Carlos
    Mendes, Diogo
    Batel-Marques, Francisco
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 25 - 25
  • [3] Comparative risk of infections among JAK inhibitors used in rheumatoid arthritis: A network meta-analysis of clinical trials
    Alves, Carlos
    Mendes, Diogo
    Penedones, Ana
    Marques, Francisco Batel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 130 - 130
  • [4] Comparative safety of JAK inhibitors in patients with rheumatoid arthritis: A network meta-analysis of clinical trials
    Alves, Carlos
    Mendes, Diogo
    Penedones, Ana
    Marques, Francisco Batel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 130 - 130
  • [5] Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis
    Yates, Mark
    Mootoo, Amanda
    Adas, Maryam
    Bechman, Katie
    Rampes, Sanketh
    Patel, Vishit
    Qureshi, Sumera
    Cope, Andrew P.
    Norton, Sam
    Galloway, James B.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 779 - 788
  • [6] MAJOR ADVERSE CARDIAC EVENTS AND VENOUS THROMBOEMBOLISM RISK WITH JAK INHIBITORS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Maqsood, Muhammad Haisum
    Ottensoser, Molly
    Berger, Jeffrey S.
    Bangalore, Sripal
    Garshick, Michael Seth
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1796 - 1796
  • [7] Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis A Systematic Review and Network Meta-analysis
    Alves, Carlos
    Penedones, Ana
    Mendes, Diogo
    Marques, Francisco Batel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : 69 - 76
  • [8] Risk of venous thromboembolism in patients with rheumatoid arthritis: a meta-analysis of observational studies
    Zahra A Fazal
    Ana Michelle Avina-Galindo
    Shelby Marozoff
    Jessie Kwan
    Na Lu
    J. Antonio Avina-Zubieta
    BMC Rheumatology, 8
  • [9] Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis
    Ungprasert, Patompong
    Srivali, Narat
    Spanuchart, Ittikorn
    Thongprayoon, Charat
    Knight, Eric L.
    CLINICAL RHEUMATOLOGY, 2014, 33 (03) : 297 - 304
  • [10] Risk of venous thromboembolism in patients with rheumatoid arthritis: a meta-analysis of observational studies
    Fazal, Zahra A.
    Avina-Galindo, Ana Michelle
    Marozoff, Shelby
    Kwan, Jessie
    Lu, Na
    Avina-Zubieta, J. Antonio
    BMC RHEUMATOLOGY, 2024, 8 (01)
12345